April 30th 2025
Respiratory diseases made up the hospitalizations in older adults after they were exposed to wildfire smoke.
April 28th 2025
Smoking prevalence is projected to decline by 2035, yet health consequences persist due to slower reductions among older adults.
February 13th 2025
Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline at 52 weeks in the phase 3 FIBRONEER-ILD trial.
December 16th 2024
Both candidates combine 2 already licensed vaccines to prevent influenza and COVID-19.
December 10th 2024
These data from the Environmental Protection Agency were presented at the Society for Risk Analysis annual meeting.
Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies
Lidocaine Spray Shows Promise for Chronic Cough, Study Says
Longer, More Intense Pollen Seasons Driven by Human-Led Climate Change, Study Says
What We’re Reading: Panel to Hear J&J EUA Application; Senate Passes Relief Package; Heavy Metals in Baby Food
Dr Krishna Sundar: Cough Hypersensitivity Is a Key Target for Patients With Chronic Cough
Determinants of ICS Therapy Adherence in Patients With Asthma
COPD and Asthma May Not Be Risk Factors for COVID-19, Study Says
What We’re Reading: J&J, Novavax Release COVID-19 Vaccine Data; Undercounted Nursing Home Deaths; Experts Encourage Double Masking
This Week in Managed Care: January 8, 2021
What We're Reading: FDA Stands Fast on COVID-19 Vaccine Dosing; Haven Dissolves; Moderna Boosts Dose Supply
A Timeline of COVID-19 Developments in 2020
Dr Megan Althoff on How, Why the GINA, ERS/ATS Guidelines Differ
Top 5 Most-Read Respiratory Stories of 2020
Dr Nicola Hanania: Exacerbation Improvement Is an Important Indicator of Patient Response to Biologics
What We’re Reading: US Buys More Pfizer Vaccine; Walmart Sued Over Opioid Crisis; 2020's Deadly Toll
Top 5 Most-Read COVID-19 News of 2020
FDA Panel Backs Moderna COVID-19 Vaccine; EUA Expected Next
COVID-19 and Health Disparities: An Opportunity to Refocus Resources?
Dr Anne Reihman: Latest Respiratory Research Lacks a Definition for “Adequate Response” in Biologics
COVID-19 and Health Disparities: Preexisting Factors Impact Exposure, Recovery
Study Finds Young People Quit or Reduced Vaping Habits During the Pandemic
What We’re Reading: Record COVID-19 Deaths, Hospitalizations; CDC Revises Quarantine Guidelines; Moderna to Begin Pediatric Vaccine Trial
Dr Dan Ouellette: The New ERS/ATS Guidelines Provide Information on Biologic Agents
Why Even the Threat of a Twindemic Isn’t Swaying the Most Vulnerable: Black Women
Dr Megan Althoff: Updated GINA Guidelines Include Reliever Treatment With an Inhaled Corticosteroid
What We’re Reading: Efficacy of AstraZeneca Vaccine; FDA Grants EUA for Antibody Cocktail; Assessing Ventilator Usage
Self-Management Education, Vaccines, Other Asthma Interventions Could Reduce Health Spending and Utilization
What We’re Reading: Pfizer to Submit EUA Application; WHO Recommends Against Remdesivir; CDC Warns Against Holiday Travel
Implementing Certain Asthma Interventions Could Reduce Health Spending, Utilization
Dr Anthony Loschner Expounds on the Benefits of AI in Pulmonary Medicine
What We’re Reading: FDA Authorizes Antibody Treatment; ND Attempts to Ease Stress on Hospitals; Fruit Consumption Among Children